Literature DB >> 33426628

Attenuation of the Induction of TLRs 2 and 4 Mitigates Inflammation and Promotes Neurological Recovery After Focal Cerebral Ischemia.

Koteswara Rao Nalamolu1,2, Siva Reddy Challa1, Casimir A Fornal1, Natalia A Grudzien1, Laura C Jorgenson1, Mouneeb M Choudry1, Nathan J Smith3, Cassandra J Palmer1, David M Pinson4, Jeffrey D Klopfenstein1,5, Krishna Kumar Veeravalli6,7,8.   

Abstract

The intense inflammatory response triggered in the brain after focal cerebral ischemia is detrimental. Recently, we showed that the suppression of toll-like receptors (TLRs) 2 and 4 attenuates infarct size and reduces the expression of pro-inflammatory cytokines in the ischemic brain. In this study, we further examined the effect of unsuppressed induction of TLRs 2 and 4 on the expression of its downstream signaling molecules and pro-inflammatory cytokines 1 week after reperfusion. The primary purpose of this study was to investigate the effect of simultaneous knockdown of TLRs 2 and 4 on M1/M2 microglial polarization dynamics and post-stroke neurological deficits and the recovery. Transient focal cerebral ischemia was induced in young adult male Sprague-Dawley rats by the middle cerebral artery occlusion (MCAO) procedure using a monofilament suture. Appropriate cohorts of rats were treated with a nanoparticle formulation of TLR2shRNA and TLR4shRNA (T2sh+T4sh) expressing plasmids (1 mg/kg each of T2sh and T4sh) or scrambled sequence inserted vector (vehicle control) expressing plasmids (2 mg/kg) intravenously via tail vein immediately after reperfusion. Animals from various cohorts were euthanized during reperfusion, and the ischemic brain tissue was isolated and utilized for PCR followed by agarose gel electrophoresis, real-time PCR, immunoblot, and immunofluorescence analysis. Appropriate groups were subjected to a battery of standard neurological tests at regular intervals until 14 days after reperfusion. The increased expression of both TLRs 2 and 4 and their downstream signaling molecules including the pro-inflammatory cytokines was observed even at 1-week after reperfusion. T2sh+T4sh treatment immediately after reperfusion attenuated the post-ischemic inflammation, preserved the motor function, and promoted recovery of the sensory and motor functions. We conclude that the post-ischemic induction of TLRs 2 and 4 persists for at least 7 days after reperfusion, contributes to the severity of acute inflammation, and impedes neurological recovery. Unlike previous studies in TLRs 2 or 4 knockout models, results of this study in a pharmacologically relevant preclinical rodent stroke model have translational significance.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Inflammation; Ischemia; Motor function; Recovery; Reperfusion; Sensory function

Mesh:

Year:  2021        PMID: 33426628      PMCID: PMC8272739          DOI: 10.1007/s12975-020-00884-z

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.800


  64 in total

1.  Broad expression of Toll-like receptors in the human central nervous system.

Authors:  Malika Bsibsi; Rivka Ravid; Djordje Gveric; Johannes M van Noort
Journal:  J Neuropathol Exp Neurol       Date:  2002-11       Impact factor: 3.685

2.  Cultured astrocytes express toll-like receptors for bacterial products.

Authors:  Christal C Bowman; Amy Rasley; Susanne L Tranguch; Ian Marriott
Journal:  Glia       Date:  2003-09       Impact factor: 7.452

Review 3.  The harms and benefits of inflammatory and immune responses in vascular disease.

Authors:  Angel Chamorro; John Hallenbeck
Journal:  Stroke       Date:  2006-01-12       Impact factor: 7.914

Review 4.  Inflammatory mediators and stroke: new opportunities for novel therapeutics.

Authors:  F C Barone; G Z Feuerstein
Journal:  J Cereb Blood Flow Metab       Date:  1999-08       Impact factor: 6.200

5.  TLR signaling tailors innate immune responses in human microglia and astrocytes.

Authors:  Carolyn S Jack; Nathalie Arbour; Joshua Manusow; Vivianne Montgrain; Manon Blain; Ellie McCrea; Aaron Shapiro; Jack P Antel
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

Review 6.  Role of inflammation and its mediators in acute ischemic stroke.

Authors:  Rong Jin; Lin Liu; Shihao Zhang; Anil Nanda; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2013-09-05       Impact factor: 4.132

7.  The evolution of vertebrate Toll-like receptors.

Authors:  Jared C Roach; Gustavo Glusman; Lee Rowen; Amardeep Kaur; Maureen K Purcell; Kelly D Smith; Leroy E Hood; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

8.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.

Authors:  Julie K Olson; Stephen D Miller
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

Review 10.  Inflammatory Disequilibrium in Stroke.

Authors:  Danica Petrovic-Djergovic; Sascha N Goonewardena; David J Pinsky
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

View more
  6 in total

1.  Ulinastatin alleviates early brain injury after traumatic brain injury by inhibiting oxidative stress and apoptosis.

Authors:  Xiaoyan Feng; Weiwei Ma; Junhui Chen; Wei Jiao; Yuhai Wang
Journal:  Acta Cir Bras       Date:  2022-04-20       Impact factor: 1.564

Review 2.  DAMPs and RAGE Pathophysiology at the Acute Phase of Brain Injury: An Overview.

Authors:  Baptiste Balança; Laurent Desmurs; Jérémy Grelier; Armand Perret-Liaudet; Anne-Claire Lukaszewicz
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

3.  Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Hui Xia; Ziyao Wang; Min Tian; Zunjing Liu; Zhenhua Zhou
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

4.  Cerebrolysin alleviates early brain injury after traumatic brain injury by inhibiting neuroinflammation and apoptosis via TLR signaling pathway.

Authors:  Weihong Lu; Zhonghua Zhu; Dongliang Shi; Xiaoyu Li; Jingzhi Luo; Xingzhi Liao
Journal:  Acta Cir Bras       Date:  2022-09-05       Impact factor: 1.564

5.  Therapeutic efficacy of matrix metalloproteinase-12 suppression on neurological recovery after ischemic stroke: Optimal treatment timing and duration.

Authors:  Siva Reddy Challa; Koteswara Rao Nalamolu; Casimir A Fornal; Billy C Wang; Ryan C Martin; Elsa A Olson; Ammar L Ujjainwala; David M Pinson; Jeffrey D Klopfenstein; Krishna Kumar Veeravalli
Journal:  Front Neurosci       Date:  2022-10-04       Impact factor: 5.152

Review 6.  Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders.

Authors:  Rezan Ashayeri Ahmadabad; Zahra Mirzaasgari; Ali Gorji; Maryam Khaleghi Ghadiri
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.